LabStyle Innovations receives U.S. Notice of Allowance for key patent relating to the Dario blood glucose monitoring device

May 2, 2014 4:28 pm

May 1, 2014 – Caesarea, Israel – LabStyle Innovations Corp. (OTCQB:DRIO), developer of the Dario™ Diabetes Management Solution, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for core patent claims covering the company’s personalized blood glucose monitoring device.

LabStyle’s now patent pending invention, entitled “FLUID TESTING APPARATUS AND METHODS OF USE”, specifically relates to how the Dario™ blood glucose monitor draws power from and transmits data to a smart phone via the audio jack port.  This device is designed to work in tandem with LabStyle’s novel and powerful Dario™ software application to form the overall Dario™ Diabetes Management Solution.
Read More